The LDL receptor, Arterioscler Thromb Vasc Biol, vol.29, issue.4, pp.431-439, 2009. ,
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, vol.34, issue.45, pp.3478-90, 2013. ,
Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia, Atherosclerosis, vol.239, issue.1, pp.158-62, 2015. ,
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society, Eur Heart J, vol.35, issue.32, pp.2146-57, 2014. ,
JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia, Hepatology, vol.56, issue.6, pp.2163-71, 2012. ,
Disease-corrected hepatocyte-like cells from familial hypercholesterolemiainduced pluripotent stem cells, Mol Biotechnol, vol.54, issue.3, pp.863-73, 2013. ,
Restoration of physiologically responsive low-density lipoprotein receptormediated endocytosis in genetically deficient induced pluripotent stem cells, Sci Rep, vol.5, p.13231, 2015. ,
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J Clin Invest, vol.120, issue.9, pp.3127-3163, 2010. ,
Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells, Stem Cell Rev, vol.6, issue.4, pp.622-654, 2010. ,
CRISPR/Cas9: at the cutting edge of hepatology, Gut, vol.66, issue.7, pp.1329-1369, 2017. ,
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease, Sci Rep, vol.7, p.44624, 2017. ,
CRISPR/Cas9 therapeutics for liver diseases, J Cell Biochem, vol.119, issue.6, pp.4265-78, 2018. ,
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges, Expert Opin Drug Deliv, vol.15, issue.9, pp.905-918, 2018. ,
Safe harbours for the integration of new DNA in the human genome, Nat Rev Cancer, vol.12, issue.1, pp.51-59, 2011. ,
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus, J Hepatol, vol.46, issue.3, pp.411-420, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00374413
Role of low-density lipoprotein receptor in the hepatitis C virus life cycle, Hepatology, vol.55, issue.4, pp.998-1007, 2012. ,
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease, Viruses, vol.5, issue.5, pp.1292-324, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00850889
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nat Med, vol.11, issue.7, pp.791-797, 2005. ,
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes, Gastroenterology, vol.139, issue.4, pp.1355-64, 2010. ,
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model, J Clin Invest, vol.124, issue.11, pp.4953-64, 2014. ,
A more efficient method to generate integration-free human iPS cells, Nat Methods, vol.8, issue.5, pp.409-421, 2011. ,
RNA-guided human genome engineering via Cas9, Science, vol.339, issue.6121, pp.823-829, 2013. ,
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells, Hepatology, vol.60, issue.2, pp.700-714, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01169803
Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: impact on production of lipo-viro-particles, Gut, vol.66, issue.12, pp.2160-2169, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01366451
A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication, J Med Virol, vol.79, issue.2, pp.155-60, 2007. ,
Multicenter trials need to use the same assay for hepatitis C virus viral load determination, J Clin Microbiol, vol.45, issue.11, pp.3788-90, 2007. ,
Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment, J Viral Hepat, vol.16, issue.10, pp.705-720, 2009. ,
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, issue.3, pp.581-590, 2015. ,
Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes, Stem Cell Rep, vol.5, issue.6, pp.1250-62, 2015. ,
Transplantation of hESC-derived hepatocytes protects mice from liver injury, Stem Cell Res Ther, vol.6, p.246, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01254139
Stagespecific regulation of the WNT/beta-catenin pathway enhances differentiation of hESCs into hepatocytes, J Hepatol, vol.64, issue.6, pp.1315-1341, 2016. ,
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells, Sci Rep, vol.6, p.37388, 2016. ,
Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences, J Clin Invest, vol.76, issue.3, pp.1113-1135, 1985. ,
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, vol.34, issue.2, pp.154-160, 2003. ,
DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter, Nucleic Acids Res, vol.27, issue.4, pp.1104-1121, 1999. ,
PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells, Curr Opin Lipidol, vol.25, issue.5, pp.387-93, 2014. ,
CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells, Hepatol Commun, vol.1, issue.9, pp.886-98, 2017. ,
Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration, Stem Cells, vol.26, issue.2, pp.496-504, 2008. ,
Efficient recombinasemediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition, Stem Cell Rep, vol.5, issue.5, pp.918-949, 2015. ,
Functional analysis of LDLR promoter and 5? UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia, Hum Mutat, vol.32, issue.8, pp.868-72, 2011. ,
Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates, Hepatology, vol.49, issue.3, pp.950-959, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00326130
Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants, BMC Biol, vol.16, issue.1, p.70, 2018. ,
PCSK9 inhibitors in the prevention of cardiovascular disease, J Thromb Thrombolysis, vol.42, issue.3, pp.405-424, 2016. ,
Human cholesterol metabolism and therapeutic molecules, Exp Physiol, vol.93, issue.1, pp.27-42, 2008. ,
Generation of human liver chimeric mice with hepatocytes from familial hypercholesterolemia induced pluripotent stem cells, Stem Cell Rep, vol.8, issue.3, pp.605-623, 2017. ,
Entry and release of hepatitis C virus in polarized human hepatocytes, J Virol, vol.91, issue.18, pp.478-495, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02104456
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor, Virology, vol.394, issue.1, pp.99-108, 2009. ,
Lipoprotein receptors redundantly participate in entry of hepatitis C virus, PLoS Pathog, vol.12, issue.5, p.1005610, 2016. ,